IO Biotech, Inc. Contracts & Agreements
28 Contracts & Agreements
- Business Finance (16 contracts)
- Business Operations (8)
- Human Resources (1)
- Uncategorized (3)
- Registration Rights Agreement, dated December 19, 2024, by and between the Company and EIB (Filed With SEC on December 20, 2024)
- Warrant Issuance Agreement, dated December 19, 2024, by and between the Company and EIB (Filed With SEC on December 20, 2024)
- Side Letter, dated December 19, 2024, by and between the Borrower and EIB (Filed With SEC on December 20, 2024)
- Guarantee Agreement, dated December 19, 2024, by and between the Company and EIB (Filed With SEC on December 20, 2024)
- Finance Contract, dated December 19, 2024, by and between the Borrower and EIB (Filed With SEC on December 20, 2024)
- Form of Warrant (Filed With SEC on December 20, 2024)
- Letter Agreement, dated as of October 15, 2022, by and between IO Bio US, Inc. and Amy Sullivan (Filed With SEC on March 5, 2024)
- Description of Capital Stock (Filed With SEC on March 5, 2024)
- Severance agreement between the Registrant and Eva Ehrnrooth, dated August 10, 2023 (Filed With SEC on November 13, 2023)
- Registration Rights Agreement, dated August 7, 2023, by and among the Company and the Purchasers (Filed With SEC on August 7, 2023)
- Securities Purchase Agreement, dated August 7, 2023, by and among the Company and the Purchasers (Filed With SEC on August 7, 2023)
- Form of Warrant (Filed With SEC on August 7, 2023)
- Sales Agreement, dated February 15, 2023 by and between IO Biotech, Inc. and Cowen and Company, LLC (Filed With SEC on February 15, 2023)
- Description of Capital Stock (Filed With SEC on March 31, 2022)
- Clinical Trial Collaboration and Supply Agreement by and among IO Biotech ApS, MSD International GmbH, and MSD International Business GmbH, dated as of November 30, 2021 (Filed With SEC on December 6, 2021)
- Option Assignment Agreement, dated as of January 2, 2015, by and between IO Biotech ApS and Herlev Hospital (Filed With SEC on October 26, 2021)
- Addendum to Service Agreement, dated April 1, 2021, by and between IO Biotech ApS and Eva Ehrnrooth (Filed With SEC on October 26, 2021)
- Service Agreement, dated August 21, 2017, by and between IO Biotech ApS and Eva Ehrnrooth (Filed With SEC on October 26, 2021)
- Addendum to Service Agreement, dated April 1, 2021, by and between IO Biotech ApS and Mai-Britt Zocca (Filed With SEC on October 26, 2021)
- Service Agreement, dated August 21, 2017, by and between IO Biotech ApS and Mai-Britt Zocca (Filed With SEC on October 26, 2021)
- Clinical Trial Collaboration and Supply Agreement, dated September 7, 2021, by and among IO Biotech ApS, MSD International GmbH and MSD International Business GmbH (Filed With SEC on October 26, 2021)
- Agreement on Payment for Specific Services, dated as of January 27, 2021, by and between IO Biotech ApS and Herlev and Gentofte Hospital (Filed With SEC on October 26, 2021)
- 2nd Amendment to Option Assignment Agreement, dated as of December 7, 2018, by and between IO Biotech ApS and Herlev and Gentofte Hospital (Filed With SEC on October 26, 2021)
- 1st Amendment to Option Assignment Agreement, dated as of December 7, 2018, by and between IO Biotech ApS and Herlev and Gentofte Hospital (Filed With SEC on October 26, 2021)
- Option Assignment Agreement, dated as of March 27, 2017, by and between IO Biotech ApS and Herlev and Gentofte Hospital (Filed With SEC on October 26, 2021)
- Assignment Agreement, dated as of January 2, 2017, by and between IO Biotech ApS and Herlev and Gentofte Hospital (Filed With SEC on October 26, 2021)
- Framework Assignment Agreement, dated as of May 2, 2016, by and between IO Biotech ApS and Herlev Hospital (Filed With SEC on October 26, 2021)
- Addendum I to Option Assignment Agreement, dated as of May 2, 2016, by and between IO Biotech ApS and Herlev Hospital (Filed With SEC on October 26, 2021)
